• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Antiplatelet treatment for coronary heart disease.冠心病的抗血小板治疗。
Heart. 2007 Feb;93(2):258-65. doi: 10.1136/hrt.2005.071209.
2
Antiplatelet rather than anticoagulant therapy with coronary stenting.
Lancet. 1997 Jan 18;349(9046):146-7. doi: 10.1016/S0140-6736(97)22003-9.
3
Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts following percutaneous transluminal coronary angioplasty.经皮腔内冠状动脉成形术后大隐静脉和乳内动脉搭桥患者的抗栓治疗。
Chest. 1992 Oct;102(4 Suppl):508S-515S. doi: 10.1378/chest.102.4_supplement.508s.
4
Changing roles of anticoagulant and antiplatelet treatment during percutaneous coronary intervention.经皮冠状动脉介入治疗期间抗凝和抗血小板治疗角色的转变
Heart. 2005 Jun;91 Suppl 3(Suppl 3):iii16-9. doi: 10.1136/hrt.2004.058511.
5
Regarding antithrombotic treatment after coronary stenting in patients on chronic oral anticoagulation.
Am Heart J. 2005 Feb;149(2):E1. doi: 10.1016/j.ahj.2004.08.019.
6
Role of enoxaparin in the invasive management of the ACS patient.依诺肝素在急性冠状动脉综合征患者侵入性治疗中的作用。
J Invasive Cardiol. 2004 Feb;16(2):52-3.
7
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.冠状动脉支架置入术后抗血小板治疗与抗凝治疗的随机对照比较。
N Engl J Med. 1996 Apr 25;334(17):1084-9. doi: 10.1056/NEJM199604253341702.
8
[Anticoagulants and antiaggregants in ischemic heart disease].[缺血性心脏病中的抗凝剂和抗血小板剂]
G Ital Cardiol. 1990 Aug;20(8):746-57.
9
New players in the field of antiplatelet and anticoagulant therapy in coronary heart disease - current therapeutic issues and hot topics.冠心病抗血小板和抗凝治疗领域的新参与者——当前的治疗问题和热点话题。
Ther Adv Cardiovasc Dis. 2009 Dec;3(6):413-21. doi: 10.1177/1753944709354031. Epub 2009 Nov 16.
10
Angioplasty, restenosis, and antiplatelet therapy.血管成形术、再狭窄与抗血小板治疗。
Transplant Proc. 1989 Aug;21(4):3685.

引用本文的文献

1
Prevalence and risk factors for proximal deep vein thrombosis at admission in patients with traumatic fractures: a multicenter retrospective study.创伤性骨折患者入院时近端深静脉血栓形成的患病率及危险因素：一项多中心回顾性研究
Front Cardiovasc Med. 2024 Apr 25;11:1372268. doi: 10.3389/fcvm.2024.1372268. eCollection 2024.
2
Synthesis and Biological Evaluation of Novel Thiadiazole Derivatives as Antiplatelet Agents.新型噻二唑衍生物作为抗血小板药物的合成及生物学评价
Iran J Pharm Res. 2024 Jan 7;22(1):e141846. doi: 10.5812/ijpr-141846. eCollection 2023 Jan-Dec.
3
Effect of anti-platelet therapy on peri-operative blood loss in patients undergoing off-pump coronary artery bypass grafting.抗血小板治疗对非体外循环冠状动脉旁路移植术患者围手术期失血的影响。
Ann Card Anaesth. 2022 Apr-Jun;25(2):182-187. doi: 10.4103/aca.aca_12_22.
4
Diet affects glycosylation of serum proteins in women at risk for cardiometabolic disease.饮食影响心血管代谢疾病风险女性血清蛋白的糖基化。
Eur J Nutr. 2021 Oct;60(7):3727-3741. doi: 10.1007/s00394-021-02539-7. Epub 2021 Mar 26.
5
Effect of Ticagrelor, a Cytochrome P450 3A4 Inhibitor, on the Pharmacokinetics of Tadalafil in Rats.细胞色素P450 3A4抑制剂替格瑞洛对大鼠他达拉非药代动力学的影响。
Pharmaceutics. 2019 Jul 20;11(7):354. doi: 10.3390/pharmaceutics11070354.
6
Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with vascular erectile dysfunction: a comparative randomized prospective study.他达拉非联合阿司匹林与他达拉非或阿司匹林单药治疗血管性勃起功能障碍患者的疗效和安全性：一项比较随机前瞻性研究。
Int Urol Nephrol. 2019 Sep;51(9):1491-1499. doi: 10.1007/s11255-019-02211-4. Epub 2019 Jun 22.
7
Clinical utility of mean platelet volume and immature platelet fraction in acute coronary syndrome.平均血小板体积和未成熟血小板分数在急性冠脉综合征中的临床应用。
Biomed J. 2019 Apr;42(2):107-115. doi: 10.1016/j.bj.2018.12.005. Epub 2019 May 8.
8
Formulation of cilostazol spherical agglomerates by crystallo-co-agglomeration technique and optimization using design of experimentation.通过结晶共附聚技术制备西洛他唑球形附聚物并采用实验设计进行优化。
Int J Pharm Investig. 2017 Oct-Dec;7(4):164-173. doi: 10.4103/jphi.JPHI_39_17.
9
First Safety and Performance Evaluation of T45K, a Self-Assembling Peptide Barrier Hemostatic Device, After Skin Lesion Excision.自组装肽屏障止血装置T45K在皮肤病变切除后的首次安全性和性能评估。
Dermatol Surg. 2018 Jul;44(7):939-948. doi: 10.1097/DSS.0000000000001468.
10
Antiplatelet (aspirin) therapy as a new option in the treatment of vasculogenic erectile dysfunction: a prospective randomized double-blind placebo-controlled study.抗血小板（阿司匹林）治疗作为血管源性勃起功能障碍治疗的新选择：一项前瞻性随机双盲安慰剂对照研究。
Int Urol Nephrol. 2018 Mar;50(3):411-418. doi: 10.1007/s11255-018-1786-0. Epub 2018 Jan 17.

本文引用的文献

1
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.在氯吡格雷预处理后接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者中使用阿昔单抗：ISAR-REACT 2随机试验
JAMA. 2006 Apr 5;295(13):1531-8. doi: 10.1001/jama.295.13.joc60034. Epub 2006 Mar 13.
2
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.氯吡格雷与阿司匹林联用对比单用阿司匹林预防动脉粥样硬化血栓形成事件
N Engl J Med. 2006 Apr 20;354(16):1706-17. doi: 10.1056/NEJMoa060989. Epub 2006 Mar 12.
3
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.45852例急性心肌梗死患者中氯吡格雷联合阿司匹林治疗：随机安慰剂对照试验。
Lancet. 2005 Nov 5;366(9497):1607-21. doi: 10.1016/S0140-6736(05)67660-X.
4
The lady aspirin for cardiovascular disease.用于心血管疾病的低剂量阿司匹林。 （注：原英文表述有误，推测正确表述可能是“The low-dose aspirin for cardiovascular disease” ，这里按推测的正确内容翻译）
Lancet. 2005 Oct 1;366(9492):1148-50. doi: 10.1016/S0140-6736(05)67462-4.
5
Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.对31项随机对照试验中纳入的192,036例患者使用不同剂量阿司匹林后出血并发症风险的分析。
Am J Cardiol. 2005 May 15;95(10):1218-22. doi: 10.1016/j.amjcard.2005.01.049.
6
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.经皮冠状动脉介入治疗指南。欧洲心脏病学会经皮冠状动脉介入治疗特别工作组。
Eur Heart J. 2005 Apr;26(8):804-47. doi: 10.1093/eurheartj/ehi138. Epub 2005 Mar 15.
7
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.在阿司匹林和纤溶治疗基础上加用氯吡格雷用于ST段抬高型心肌梗死。
N Engl J Med. 2005 Mar 24;352(12):1179-89. doi: 10.1056/NEJMoa050522. Epub 2005 Mar 9.
8
Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study.高负荷剂量氯吡格雷降低冠状动脉介入治疗患者围手术期心肌梗死的随机试验：ARMYDA-2（血管成形术期间减少心肌损伤的抗血小板治疗）研究结果
Circulation. 2005 Apr 26;111(16):2099-106. doi: 10.1161/01.CIR.0000161383.06692.D4. Epub 2005 Mar 6.
9
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.在接受高负荷剂量氯吡格雷治疗后行择期经皮冠状动脉介入治疗的糖尿病患者中使用阿昔单抗的随机临床试验。
Circulation. 2004 Dec 14;110(24):3627-35. doi: 10.1161/01.CIR.0000148956.93631.4D. Epub 2004 Nov 7.
10
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.氯吡格雷抵抗与急性心肌梗死患者复发性动脉粥样硬化血栓形成事件风险增加相关。
Circulation. 2004 Jun 29;109(25):3171-5. doi: 10.1161/01.CIR.0000130846.46168.03. Epub 2004 Jun 7.

Antiplatelet treatment for coronary heart disease.

作者信息

Clappers N, Brouwer M A, Verheugt F W A

机构信息

Radboud University Nijmegen Medical Center, Heartcenter, 670 Cardiology, PO Box 9101, Nijmegen, The Netherlands 6500 HB.

出版信息

Heart. 2007 Feb;93(2):258-65. doi: 10.1136/hrt.2005.071209.

DOI:10.1136/hrt.2005.071209
PMID:17228079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1861405/
Abstract
摘要